Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-30

Clinical Trial Update: Cardiovascular Protection After Preeclampsia With Enalapril [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating enalapril for cardiovascular protection after preeclampsia, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril (enalapril)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Preeclampsia, Hypertensive Disorder of Pregnancy | Phase 3 | Status: NOT_YET_RECRUITING